Stock listing
MIRM Stock Price, News, Filings & Events — Mirum Pharmaceuticals, Inc.
Selected listing: MIRM · BIVA · MXN · MX
This page tracks Mirum Pharmaceuticals, Inc.'s MIRM:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIRM:BIVA. MIRM:BIVA is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.
- Ticker
- MIRM:BIVA
- Asset type
- Stock
- Market cap
- $6.33B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- BIVA
- Currency
- MXN
Mirum Pharmaceuticals, Inc. MIRM:BIVA stock context
This page tracks Mirum Pharmaceuticals, Inc.'s MIRM:BIVA listing on BIVA in MXN for MX, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MIRM:BIVA. MIRM:BIVA is the stock-level entry point for investors researching Mirum Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mirum Pharmaceuticals, Inc. is a public company traded under the ticker MIRM in the American market. The company has a market capitalization of approximately $6.89 billion. Mirum focuses on developing innovative therapies for rare diseases, aiming to address unmet medical needs.
Latest news from Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026
July 29, 2026
Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossific...
June 14, 2026
Mirum Pharmaceuticals and Incyte Announce Pivotal Late-Breaking Results for Zilurgisertib in Fibrodysplasia Ossificans Progressiva Accept...
June 4, 2026
Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026
May 30, 2026
Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026
May 21, 2026
Mirum Pharmaceuticals, Inc. earnings calls
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2026 Earnings Call
August 5, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call
May 6, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q4 2025 Earnings Call
February 25, 2026 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q3 2025 Earnings Call
November 4, 2025 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q2 2025 Earnings Call
August 6, 2025 · Replay with transcript and chapters
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2025 Earnings Call
May 7, 2025 · Replay with transcript and chapters
Research Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for MIRM:BIVA.
Mirum Pharmaceuticals, Inc. company profile
View the public company page for Mirum Pharmaceuticals, Inc. on 6ix.
Mirum Pharmaceuticals, Inc. news
Read company news and market updates connected to Mirum Pharmaceuticals, Inc..
Mirum Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Mirum Pharmaceuticals, Inc..
Alternate listings
MIRM:NASDAQ
US · USD
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:TRADEGATE
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:GETTEX
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
A2PM29:LS
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:DUS
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
A2PM29:LSX
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
MIRM:BMV
MX · MXN
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:FWB
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
MIRM:BOATS
US · USD
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:HAM
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:MUN
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.
08D:SWB
DE · EUR
Alternate listing for Mirum Pharmaceuticals, Inc.; the primary context on this page is MIRM:BIVA.